Previous therapeutic approaches to prevent sickle red cell dehydration have targetted KCI cotranspot and K and CI conductances. I propose to develop the non-selective cation pathway as a therapeutic target. I have recorded unitary openings and closings of this pathway in sickle red cells and have found it to be activated by deoxygenation. I propose here to characterize the biophysical and pharmacologic properties of the channel. I will characterize the mechanisms of its activation by dehydration and will attempt to define the role of HbS polymerization in that activation. We will also define other possible modes of regulation by cell volume, by redox regulation and by small molecule or protein signalling pathways. We will compare this channel of human sickle cells to hypothesized counterparts in red cells from a mouse model of sickle cell disease. The information gained from these studies will assist in the molecular identification of the channel polypeptide and will accelerate development of this channel as a therapeutic target.
The specific aims of the proposal are: (1) Test the hypothesis that the erythroid cation channel is uprequlated or dysrequlated in sickle cell disease. The experiments of this aim will define the biophysical and pharmacological properties of cation channel activity in HbSS and HbAA erythrocytes. They will further define the stimulatory and inhibitory regulators of these channel activities, with a particular focus on hypoxia as a stimulatory regulator. (2) Test the hypothesis that stimulation of cation channel activity in HbSS erythrocytes by deoxyqenation is mediated by or requires polymerization of HbSS and/or its sequellae. (3) Test the hypothesis that erythroid cation channel dysrequlation of sickle cell disease is mirrored by similar dysregulation in red cells of mouse models of sickle cell disease. The experiments of this aim will extend the findings of Aim 1 to characterize the cation channel activity of mouse erythrocytes expressing with HbSAD in he presence of some mouse Hb or expressing almost entirely human HbS.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL073112-01
Application #
6602023
Study Section
Special Emphasis Panel (ZHL1-CSR-B (F1))
Program Officer
Qasba, Pankaj
Project Start
2003-03-17
Project End
2005-02-28
Budget Start
2003-03-17
Budget End
2004-02-29
Support Year
1
Fiscal Year
2003
Total Cost
$160,200
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Alper, Seth L; Vandorpe, David H; Peters, Luanne L et al. (2008) Reduced DIDS-sensitive chloride conductance in Ae1-/- mouse erythrocytes. Blood Cells Mol Dis 41:22-34
Chernova, Marina N; Jiang, Lianwei; Friedman, David J et al. (2005) Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: differences in anion selectivity, regulation, and electrogenicity. J Biol Chem 280:8564-80
Begenisich, Ted; Nakamoto, Tesuji; Ovitt, Catherine E et al. (2004) Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4. J Biol Chem 279:47681-7